Opioid Addiction Treatment. Thomas R. Kosten, MD Professor of Psychiatry Baylor College of Medicine
|
|
- Maria Walton
- 8 years ago
- Views:
Transcription
1 Opioid Addiction Treatment Thomas R. Kosten, MD Professor of Psychiatry Baylor College of Medicine 1
2 Continuity of Care: A Critical Goal Is shorter cheaper? Re-hospitalization in 296 dependent patients Romelsjo et al. Sweden All received at least 3 inpatient days Group 1: 1 week Inpat. Group 2: 1 week Inpat. Group 3: 8 Weeks Inpat. 10 Wks Opt No Opt No Opt
3 Re-Hospitalization and Initial Time in Tx Romelsjo et al. JSAT, % 10 Wks Opt 1 Wk Inp 8 Wks Inp 78% 71% 60% 40% 20% 21% 58% 46% 40% 0% Months After Release
4 Continuity of Care: A Critical Goal Who, Why, What Treatment? 1. Treated patients show far more improvements than non-treated patients. 2. Motivation is an important but not critical ingredient. 3. Costs in relapse and re-hospitalization associated with NOT treating. 4. Continuity in outpatient care is critical, cost effective, and requested by patients!
5 Let Me Tell You A Story WHY? Because a real case will help: Illustrate complex pattern of relapse and treatment reentry typically experienced by opioid-dependent patients. Underline importance of screening for illicit drugs.
6 Let Me Tell You A Story WHY? Because a real case will help: Demonstrate potential of new treatment paradigms which provide a way to stabilize patients in an office setting with such opioid-based medications as buprenorphine. Help us begin to see the cost-savings inherent in a new treatment paradigm.
7 Let Me Tell You A Story Mr. A, a 34 year old Caucasian man, began chipping intranasal heroin about 5 years ago.
8 Let Me Tell You A Story Mr. A, a 34 year old Caucasian man, began chipping intranasal heroin about 5 years ago.
9 Let Me Tell You A Story Then, Mr. A had a serious auto accident due to seizure and ER toxicology screen is positive for cocaine and opioids.
10 Historic Challenges in Treating Top reasons physicians ignore substance abuse: 426 Primary Care Physicians 1) Don t know what to do. 69% 2) No effective treatment. 55% 3) Not really a medical problem. 26% 4) No time. 19%
11 Historic Challenges in Treating Patients reluctant to seek help from traditional methadone clinics: In undesirable neighborhoods. Inconvenient to reach. Requiring daily attendance.
12 The Story of Mr. A, continued One year after initial treatment, Mr. A returns to ER with heroin overdose sufficient to require naloxone reversal.
13 Opioid Dependence and Other Drug Dependencies as a Chronic, Relapsing Disease State of the art science (SAMHSA, NIDA, WHO) now identifies opioid dependence as a chronic disease state.
14 Opioid Dependence as Chronic Disease We need to: Foster the idea of drug dependence as chronic illness. Promote best practices for long-term management and continuous monitoring models.
15 Continuum of Care for Chronic Disease Opioid dependence and Mainstream chronic diseases: Striking similarities in onset, course and re-occurrence. vs. Striking disparities in policy, treatment availability, treatment evaluation, and insurance coverage. [
16 Opioid Dependence as Chronic Disease For too long physicians and payors have failed to see drug dependence for what it is, a chronic disease. Consequently: Standard has been to measure progress by assessing results at some point after patients leave treatment.
17 Opioid Dependence as Chronic Disease For too long we ve measured progress by assessing results at some point after patients leave treatment. Consequently: Results have no clinical value and produce results disappointing to policy makers.
18 Opioid Dependence as Chronic Disease For too long we ve failed to see drug dependence as a chronic disease. Moreover: We ve relied on model rejected for other chronically relapsing conditions.
19 Opioid Dependence as Chronic Disease For too long we ve failed to see drug dependence for what it is, a chronic disease. In short: We ve failed to adopt chronic disease model that might work.
20 Continuum of Care When seen as chronic Disease, Opioid Dependence, fits perfectly under the banner Continuum of Care. That s why we re here today.
21 Continuum of Care for Chronic Disease Contemporary treatments for opioid dependence must be conceptualized, structured and delivered to meet the differing needs of individuals along a continuum.
22 Opioid Dependence as Chronic Disease OD more responsive to and more cost effectively treated using chronic disease management model of care.
23 Continuum of Care for Chronic Disease Conflict between new, chronic disease classification and traditional short-term medical management. Demands a Change. Demands a Shift in Policy.
24 Continuum of Care for Chronic Disease Accept that: OD requires time to correct itself. Long term maintenance requires long term reimbursement.
25 Continuum of Care for Chronic Disease Versus... Mr. A and the revolving door
26 Continuum of Care for Chronic Disease Need to establish parity in care with such chronic diseases as hypertension, diabetes and asthma.
27 Continuum of Care for Chronic Disease Remember Mr. A? In spite of extensive intervention In spite of good social supports In spite of economic opportunity In spite of vocational skills In spite of multiple detoxifications In spite of drug-free outpatient care Relapse and consumption of extensive health resources. Why?
28 Continuum of Care for Chronic Disease Because the model for his care was not based on a model for a chronic, relapsing disease.
29 Historic Treatment Options Traditional goal? Rehabilitate and Discharge.
30 Historic Treatment Options 40 70% of all addiction treatment episodes are detox-only Cost $1,750 - $2,400 per episode Re-detox within a year Average = 40% (23 78% range) 28% admitted 3+ times/yr 2000 Inspector General Report
31 Historic Treatment Options Relapse rates among diabetics or asthmatics following cessation of medication = Evidence of effectiveness of medication. VS. Relapse rates amongst drug or alcohol dependent patients following cessation of treatment = Evidence of treatment failure.
32 Treating Opioid Dependence: Changing the Paradigm Patients, like Mr. A, who would have been reluctant to seek help from traditional methadone clinics, will be willing to seek help.
33 Treating Opioid Dependence: Changing the Paradigm Make study of addiction part of med school curricula. Use medical monitoring strategies (as for other chronic diseases) to ferret out those most at risk. Shift from rehabilitation strategy to chronic care strategy. Lift insurance limits so that benefits (even incentives) apply for continued outpatient, medication and behavioral visits w/o limit on days or visits.
34 Treating Opioid Dependence: Benefits of a New Paradigm Drug dependence treatments designed to discharge patients upon resolution of acute symptoms have not been effective.
35 Treating Opioid Dependence: Requirements of a New Paradigm Drug dependence should be: Insured, treated and evaluated in the same manner as other chronic illnesses.
36 Case History: How Buprenorphine Made a Difference Buprenorphine therapy in office practice was successful for Mr. A.
37 Case History: How Suboxone Can Make a Difference For appropriate patients office-based BUP treatment is an effective and cost effective model for care.
38
Treatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction [NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)
More informationSEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK
National Institute on Drug Abuse SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK U.S. Department of Health and Human National Institutes of Health SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK The goal
More informationRe-Considering Addiction Treatment. Have We Been Thinking Correctly?
Re-Considering Addiction Treatment Have We Been Thinking Correctly? Part I FDA standards of effectiveness Do substance abuse treatments meet those standards? An FDA Perspective A Drug is Approved for An
More informationCare Management Council submission date: August 2013. Contact Information
Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing
More informationTreatment of opioid use disorders
Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence
More informationRe-Thinking Addiction Treatment: Have We Been Thinking Correctly?
Re-Thinking Addiction Treatment: Have We Been Thinking Correctly? Scope of Substance Use in the US Alcohol, Illicit & non-prescribed drugs Very Frequent Use In Specialty Treat. ~ 2,300,000 Addiction Dx
More informationDisclosure. C.R. Sullivan, MD 1. Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu. The West Virginia Model
West Virginia University School of Medicine BEHAVIORAL MEDICINE & PSYCHIATRY Morgantown, WV Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu Disclosure Reckitt Benckiser
More informationSEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK
National Institute on Drug Abuse SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK U.S. Department of Health and Human National Institutes of Health SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK The goal
More informationNational Perspectives in Medication Assisted Treatment
National Perspectives in Medication Assisted Treatment Addiction Medicine Asheville March 21,2014 Melinda Campopiano, MD Medical Officer Substance Abuse & Mental Health Services Administration Guten Appetit
More informationMinimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:
Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society
More informationU.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health
TESTIMONY of the American Medical Association before the U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health Re: Examining Legislative Proposals to Combat our Nation's
More informationJohn R. Kasich, Governor Orman Hall, Director
John R. Kasich, Governor Orman Hall, Director 2 3 Epidemics of unintentional drug overdoses in Ohio, 1979-2011 1,2,3 1800 1600 1400 1200 1000 800 Prescription drugs are causing a larger overdose epidemic
More informationHave we evaluated addiction treatment correctly? Implications from a chronic care perspective
EDITORIAL Have we evaluated addiction treatment correctly? Implications from a chronic care perspective The excellent reviews of alcohol treatment outcomes and methods for evaluating and comparing treatment
More informationThis module will assist participants to:
BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module V: Coordinated Care Effective Coordination of Care Effective coordination combines the strengths of various systems
More informationIntake Consultation and Assessment Before Detox. What Happens During Drug Detox?
What Happens During Drug Detox? Many addicts and alcoholics believe they can quit using substances on their own. But after a few painful and confidence-crushing failed attempts, the need for an inpatient
More informationPutting Addiction Treatment Medications to Use: Lessons Learned
Putting Addiction Treatment Medications to Use: Lessons Learned George E. Woody, M.D. Laura McNicholas, M.D., Ph.D. Department of Psychiatry, University of Pennsylvania School of Medicine and Philadelphia
More informationIN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act
IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This
More informationAlcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem. Thomas Kosten MD
Alcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem Thomas Kosten MD Waggoner Chair & Professor of Psychiatry & Neuroscience Baylor College of Medicine Past-President,
More informationOpiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio
Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,
More informationBeyond SBIRT: Integrating Addiction Medicine into Primary Care
Beyond SBIRT: Integrating Addiction Medicine into Primary Care Community Clinic Association of Los Angeles County 14 th Annual Health Care Symposium March 6, 2015 Keith Heinzerling MD, Karen Lamp MD; Allison
More informationToday s Topics. Session 2: Introduction to Drug Treatment. Treatment matching. Guidelines: where should a client go for treatment?
Session 2: Introduction to Drug Treatment Today s Topics Level of care determination How to know when treatment works What does treatment include Description of treatment modalities Naomi Weinstein, MPH
More informationopiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380
opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 ed #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380 effects of alcohol in the brain 100 Top 30 698 heroin addiction 100
More informationPrescriber Behavior, Pain Treatment and Addiction Treatment
Prescriber Behavior, Pain Treatment and Addiction Treatment Mary Fleming, M.S. Director, Office of Policy, Planning, and Innovation Substance Abuse and Mental Health Services Administration NGA Policy
More informationThe NJSAMS Report. Heroin Admissions to Substance Abuse Treatment in New Jersey. In Brief. New Jersey Substance Abuse Monitoring System.
New Jersey Substance Abuse Monitoring System The NJSAMS Report May 2011 Admissions to Substance Abuse Treatment in New Jersey eroin is a semi-synthetic opioid drug derived from morphine. It has a high
More informationWelcome. This presentation is designed for people working in criminal justice and drug abuse treatment settings. It provides an overview of drug
Welcome. This presentation is designed for people working in criminal justice and drug abuse treatment settings. It provides an overview of drug abuse treatment principles for individuals involved in the
More informationUsing Buprenorphine in an Opioid Treatment Program
Using Buprenorphine in an Opioid Treatment Program Thomas E. Freese, PhD Director of Training, UCLA Integrated Substance Abuse Programs Director, Pacific Southwest Addiction Technology Transfer Center
More informationThe Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section
The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section TITLE I: PREVENTION SUBTITLE A- PRESCRIBER EDUCATION PRACTITIONER EDUCATION This subtitle requires practitioners who
More informationBuprenorphine Therapy in Addiction Treatment
Buprenorphine Therapy in Addiction Treatment Ken Roy, MD, FASAM Addiction Recovery Resources, Inc. River Oaks Hospital Tulane Department of Psychiatry www.arrno.org Like Minded Doc What is MAT? Definition
More informationIntegrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings
Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings All-Ohio Conference 3/27/2015 Christina M. Delos Reyes, MD Medical Consultant,
More informationOpioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
More informationOVERVIEW OF MEDICATION ASSISTED TREATMENT
Sarah Akerman MD Assistant Professor of Psychiatry Director of Addiction Services Geisel School of Medicine/Dartmouth-Hitchcock Medical Center OVERVIEW OF MEDICATION ASSISTED TREATMENT Conflicts of Interest
More informationSuboxone Programs: Treating Opioid Dependence in CHCs Andrew Putney, MD Medical Director SSTAR ATS and CHC, Fall River, Massachusetts
Suboxone Programs: Treating Opioid Dependence in CHCs Andrew Putney, MD Medical Director SSTAR ATS and CHC, Fall River, Massachusetts Educational Objectives: Review epidemiology of opioid addiction in
More informationFoundations Recovery Network (FRN) Announces Groundbreaking Opiate Research Study Which Yields Compelling Results
Foundations Recovery Network (FRN) Announces Groundbreaking Opiate Research Study Which Yields Compelling Results Results validate FRN s system of care approach through patient satisfaction Siobhan A.
More informationUsing Drugs to Treat Drug Addiction How it works and why it makes sense
Using Drugs to Treat Drug Addiction How it works and why it makes sense Jeff Baxter, MD University of Massachusetts Medical School May 17, 2011 Objectives Biological basis of addiction Is addiction a chronic
More informationConsiderations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT
Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA
More informationLimiting the Duration of Medication Assisted Treatment for Opioid Addiction: Will New State Policies Help or Hurt?
Limiting the Duration of Medication Assisted Treatment for Opioid Addiction: Will New State Policies Help or Hurt? Medicaid Evidence-Based Decisions Project June 25, 2014 Supported by National Institute
More informationNew York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery
New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery USING THE 48 HOUR OBSERVATION BED USING THE 48 HOUR OBSERVATION BED Detoxification
More informationA Drug Policy for the 21st Century
A Drug Policy for the 21st Century April 26, 2014 California Association for Alcohol and Drug Educators (CAADE) Conference Integrating Mental Health and Substance Use Disorder Services David K. Mineta,
More informationOhio Legislative Service Commission
Ohio Legislative Service Commission Bill Analysis Brian D. Malachowsky H.B. 378 130th General Assembly () Reps. Smith and Sprague BILL SUMMARY Prohibits a physician from prescribing or personally furnishing
More informationOffice-based Treatment of Opioid Dependence with Buprenorphine
Office-based Treatment of Opioid Dependence with Buprenorphine David A. Fiellin, M.D Professor of Medicine, Investigative Medicine and Public Health Yale University School of Medicine Dr. Fiellin s Disclosures
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call the
More informationTREATMENT MODALITIES. May, 2013
TREATMENT MODALITIES May, 2013 Treatment Modalities New York State Office of Alcoholism and Substance Abuse Services (NYS OASAS) regulates the addiction treatment modalities offered in New York State.
More informationAlcoholism and Substance Abuse
State of Illinois Department of Human Services Division of Alcoholism and Substance Abuse OVERVIEW The Illinois Department of Human Services, Division of Alcoholism and Substance Abuse (IDHS/DASA) is the
More informationFederal Response to Opioid Abuse Epidemic
Healthcare Committee Federal Response to Opioid Abuse Epidemic On May 1, 20215 the Energy and Commerce Subcommittee on Oversight and Investigations held a hearing entitled What is the Federal Government
More informationImpact of Systematic Review on Health Services: The US Experience
Impact of Systematic Review on Health Services: The US Experience Walter Ling MD Integrated Substance Abuse Programs (ISAP) UCLA The effectiveness of interventions for addictions: The Drug and Alcohol
More informationOPTUM By United Behavioral Health OPTUM GUIDELINE EVIDENCE BASE: Level of Care Guidelines
OPTUM By United Behavioral Health OPTUM GUIDELINE EVIDENCE BASE: Level of Care Guidelines Guideline Evaluation and Treatment Planning Discharge Planning Admission Criteria Continued Stay Criteria Discharge
More informationTreatment of Prescription Opioid Dependence
Treatment of Prescription Opioid Dependence Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse McLean Hospital, Belmont, MA Professor of Psychiatry, Harvard Medical School, Boston, MA Prescription
More informationDrugFacts: Treatment Approaches for Drug Addiction
DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please
More informationJennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry
Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings From Starting Treatment With Agonist Replacement Therapies (START) Jennifer
More informationTestimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013
Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Chairman Lee, members of the Senate Human Services Committee,
More informationMEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Sidarth Wakhlu,M.D. Addiction Team Leader North Texas VA Health Care System Addiction Psychiatry Fellowship Director Associate Professor Of Psychiatry
More informationAN INTRODUCTION ASAM
AN INTRODUCTION ASAM 2013 Ray Caesar LPC, LADC-MH Director of Addiction Specialty Programs ODMHSAS (405)522-3870 rcaesar@odmhsas.org AMERICAN SOCIETY OF ADDICTON MEDICINE ASAM ASAM is a professional organization
More informationRehab and Recovery in Allegheny County
September 2013 Rehab and Recovery in Allegheny County Allegheny HealthChoices, Inc. (AHCI) is an innovative non-profit agency dedicated to supporting the provision of high-quality mental health and substance
More informationReforming the Response To Substance Use: A Drug Policy for the 21 st Century
Reforming the Response To Substance Use: A Drug Policy for the 21 st Century 2015 NASADAD MEETING Charleston, SC June 2, 2015 David Mineta, Deputy Director Office of Demand Reduction Office of National
More informationApril 23, 2015. are dependent on the nonmedical use of prescription pain medicines and heroin.
STATEMENT OF ROBERT L. DUPONT, MD PRESIDENT, INSTUTUTE FOR BEHAVIOR AND HEALTH, INC BEFORE THE HOUSE SUBCOMMITTEE ON OVERSIGHT AND INVESTIGATIONS REGARDING COMBATTING THE OPIOID ABUSE EPIDEMIC: PROFESSIONAL
More informationSubstance Abuse During Pregnancy: Moms on Meds. Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates
Substance Abuse During Pregnancy: Moms on Meds Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates 2010 National Survey on Drug Use and Health An estimated 4.4% of pregnant women reported
More informationA Drug Policy for the 21st Century. Office of National Drug Control Policy
A Drug Policy for the 21st Century October 18, 2014 International Nurses Society on Addictions Health Care Reform & Its Impact on Addictions Nursing: Navigating Change through the Rapids David K. Mineta,
More informationHeroin Overdose Trends and Treatment Options. Neil A. Capretto, D.O., F.A.S.A.M. Medical Director
Heroin Overdose Trends and Treatment Options Neil A. Capretto, D.O., F.A.S.A.M. Medical Director Type date here www.gatewayrehab.org Drug Overdose Deaths Increasing in Allegheny County Roberta Lojak holds
More information8/1/2014. Who We Are. BHG s Medical Mission. BHG Company Overview
Who We Are BHG s Medical Mission BHG Company Overview Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. Our treatment centers provide pharmacotherapeutic maintenance
More informationAllyse Adams PC, LICDC Oriana House, Inc.
Allyse Adams PC, LICDC Oriana House, Inc. 98 Heroin Overdose Deaths from 1/1/2015-7/26/2015 Last year enough narcotic pain medicines were prescribed to supply 67 pills to every man, woman and child In
More informationVarious therapies are used in the
National Survey of Substance Abuse Treatment Services The N-SSATS Report January 28, 2010 Overview of Opioid Treatment Programs within the United States: 2008 In Brief In 2008, a total of 1,132 (8 of all
More informationAddiction is a Brain Disease
Addiction is a Brain Disease By ALAN I. LESHNER, MD A core concept evolving with scientific advances over the past decade is that drug addiction is a brain disease that develops over time as a result of
More informationDrug Addiction Is a Disease So What Do We Do about It?
Drug Addiction Is a Disease So What Do We Do about It? L E S S O N 5 Elaborate/Evaluate Photo courtesy of Gray Wolf Ranch Wilderness Recovery Lodge. Overview Students make predictions about the success
More informationTestimony of. Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment
Testimony of Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment New York City Department of Health and Mental Hygiene before the New York City
More informationAmerican Society of Addiction Medicine
American Society Medicine Public Policy Statement on Parity in Publicly Funded Health Insurance Benefits for Treatment 1 Background The American Society Medicine has well-established policy affirming that
More informationTreatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate
More informationHow To Treat Anorexic Addiction With Medication Assisted Treatment
Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious
More informationA Plan to Include Detoxification Services as a Covered Medical Assistance Benefit
A Plan to Include Detoxification Services as a Covered Medical Assistance Benefit Alcohol and Drug Abuse Division Minnesota Department of Human Services December 2014 For more information contact: Minnesota
More informationInformation for Pharmacists
Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl
More informationProvider enews TREATING PRESCRIPTION DRUG ADDICTION
Provider enews TREATING PRESCRIPTION DRUG ADDICTION Treating addiction to prescription opioids July 2012 Several options are available for effectively treating prescription opioid addiction. These options
More informationMedication-Assisted Treatment for Opioid Addiction
Medication-Assisted Treatment for Opioid Addiction This document contains a general discussion of medications approved by the U.S. Food and Drug Administration (FDA) for use in the treatment of opioid
More informationMedication-Assisted Addiction Treatment
Medication-Assisted Addiction Treatment Molly Carney, Ph.D., M.B.A. Executive Director Evergreen Treatment Services Seattle, WA What is MAT? MAT is the use of medications, in combination with counseling
More informationAmerican Society of Addiction Medicine
American Society of Addiction Medicine Public Policy Statement on Parity in Benefit Coverage: A Joint Statement by ASAM and AMBHA The American Managed Behavioral Healthcare Association (AMBHA) and the
More informationTreatment for Addiction in the Community Reduces Drug Use, Crime and Recidivism
Treatment for Addiction in the Community Reduces Drug Use, Crime and Recidivism Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School of Medicine University
More informationEver wish you could... Quit using heroin? Protect yourself from HIV infection? Get healthier?
Ever wish you could... Quit using heroin? Protect yourself from HIV infection? Get healthier? Good News: Medical treatments called opioid (oh-pee-oyd) maintenance can help you! Injecting heroin puts you
More informationAmerican Society of Addiction Medicine
American Society of Addiction Medicine Public Policy Statement on Treatment for Alcohol and Other Drug Addiction 1 I. General Definitions of Addiction Treatment Addiction Treatment is the use of any planned,
More informationProgram Assistance Letter
Program Assistance Letter DOCUMENT NUMBER: 2004-01 DATE: December 5, 2003 DOCUMENT TITLE: Use of Buprenorphine in Health Center Substance Abuse Treatment Programs TO: All Bureau of Primary Health Care
More informationAppendices to Interim Report on the Baltimore Buprenorphine Initiative. Managed Care Organization Information Pages
Appendices to Interim Report on the Baltimore Buprenorphine Initiative Appendix A Managed Care Organization Information Pages Appendix B Buprenorphine Online Physician Training Information Packet Appendix
More informationMedication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment
Medication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment Introduction March 3, 2008 By: Suzanne Gelber, MSW, Ph.D., Managing Partner, The Avisa Group Defining Characteristics
More informationMethadone Treatment for Opiate Addiction
Methadone Treatment for Opiate Addiction Health and Human Services Finance Committee Minnesota House of Representatives December 6, 2012 Gavin Bart, MD FACP FASAM Director, Division of Addiction Medicine
More informationTestimony of The New York City Department of Health and Mental Hygiene. before the
Testimony of The New York City Department of Health and Mental Hygiene before the New York City State Assembly Committee on Alcoholism and Drug Abuse on Programs and Services for the Treatment of Opioid
More informationTreatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy
Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,
More informationOne example: Chapman and Huygens, 1988, British Journal of Addiction
This is a fact in the treatment of alcohol and drug abuse: Patients who do well in treatment do well in any treatment and patients who do badly in treatment do badly in any treatment. One example: Chapman
More informationOpioid Treatment Services, Office-Based Opioid Treatment
Optum 1 By United Behavioral Health U.S. Behavioral Health Plan, California Doing Business as OptumHealth Behavioral Solutions of California ( OHBS-CA ) 2015 Level of Care Guidelines Opioid Treatment Services,
More informationSubject: Health; food and drugs; treatment of opiate addiction. Statement of purpose: This bill proposes to require the department 6of health to
2012 Page 1 of 6 1 2 3 4 5 H.627 Introduced by Representative Pugh of South Burlington Referred to Committee on Date: Subject: Health; food and drugs; treatment of opiate addiction Statement of purpose:
More informationMEDICAL POLICY Treatment of Opioid Dependence
POLICY........ PG-0313 EFFECTIVE......11/11/14 LAST REVIEW... 07/14/15 MEDICAL POLICY Treatment of Opioid Dependence GUIDELINES This policy does not certify benefits or authorization of benefits, which
More informationLearning Objectives Review and discuss current research on the basic brain physiology of addiction
Emerging Trends in Addiction Treatment 1.0 CE NBCC, NAADAC, FCB Dr. Doug Davies, MD, ASAM Medical Director The Refuge A Healing Place, Ocklawaha, FL 14835 SE 85 th Street Ocklawaha, FL 32179 www.therefuge
More informationTreatment Resources for Substance Use Disorders
Treatment Resources for Substance Use Disorders The treatment of substance use disorders can be very complex; there are many levels of care and the treatment network can be challenging to navigate. Substance
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: CSD - Suboxone Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Analgesics and Antipyretics (Opiate Partial Agonists) Client: County of San
More informationSubject: Health; food and drugs; treatment of opiate addiction. Statement of purpose: This bill proposes to require the department 6of health to
2012 Page 1 of 8 1 2 3 4 5 H.627 Introduced by Representative Pugh of South Burlington Referred to Committee on Date: Subject: Health; food and drugs; treatment of opiate addiction Statement of purpose:
More information2015 OPIOID TREATMENT PROGRAM DESCRIPTIONS
2015 OPIOID TREATMENT PROGRAM PROGRAM DESCRIPTIONS Contents Opioid T reatment Program Core Program Standards... 2 Court Treatment (CT)... 2 Detoxification... 2 Day Treatment... 3 Health Home (HH)... 3
More informationThe Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction
The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction James H. Barger, MD SAPC Medical Director and Science Officer Desiree A. Crevecoeur-MacPhail, Ph.D.
More informationKeep Your Mind and Body Healthy: Understanding Mental Health Providers, Care and Coverage
Keep Your Mind and Body Healthy: Understanding Mental Health Providers, Care and Coverage Our mental health is a vital part of our overall well-being. It affects how we think, how we feel, and how we act.
More informationAlcohol and Drug Treatment Beds by a Non- State Entity. HHS LOC Mental Health Subcommittee. February 24, 2013
Alcohol and Drug Treatment Beds by a Non- State Entity HHS LOC Mental Health Subcommittee February 24, 2013 Billy R. West, Jr., MSW, LCSW Executive Director About DAYMARK Our Mission: Daymark Recovery
More informationJane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture
Prescription Pain Medications and : A Changing Picture Jane Maxwell, Ph.D. Center for Social Work Research The University of Texas at Austin Disclosure to Participants Commercial Support: This educational
More informationApplicant Webinar for BJA s Drug Court Discretionary Grant Solicitation
Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation Cynthia Caporizzo, Senior Criminal Justice Advisor, Office of National Drug Control Policy (ONDCP) - Review of the administration
More informationFinancial Disclosures
Opioid Agonist Therapy: To Maintain or Not To Maintain - A Case Discussion PCSS-MAT American Psychiatric Association Drs. Ed Salsitz, John Renner, Timothy Fong April 14, 2015 Financial Disclosures Edwin
More informationWhat is Addiction Treatment?
What is Addiction Treatment? During 2000, almost 300,000 people entered addiction treatment services in New York State. On any given day, about 110,000 individuals are enrolled in New York State programs,
More informationPresentation to the Boston HIV Planning Council. Lydie Ultimo, MSW Director Bureau of Substance Abuse Services
Presentation to the Boston HIV Planning Council Lydie Ultimo, MSW Director Bureau of Substance Abuse Services Responsibilities of the Bureau of Substance Abuse Services License addiction treatment programs
More information